[1]
D. ABOUHUSSEIN, M. H. TEAIMA, A. AL-NUSEIRAT, O. BADARY, M. A. EL-NABARAWI, and R. A. EL-MONEM, “FORMULATION AND CHARACTERIZATION OF ODT USING DIFFERENT CO-PROCESS CONTAINING DACLATSVIR: IN VITRO AND IN VIVO PHARMACOKINETICS STUDY ON HEALTHY VOLUNTEERS FOR HEPATITIS C TREATMENT”, Int J App Pharm, vol. 14, no. 5, pp. 105–112, Sep. 2022.